Key antiviral treatment for COVID-19 still effective despite resistance fears
The study, published in the journal Cell Research, is one of the first to explore the full extent of SARS-CoV-2 mutations.
The study, published in the journal Cell Research, is one of the first to explore the full extent of SARS-CoV-2 mutations.
Now, world first research conducted by the University of South Australia has identified that the frequently used chemotherapy drug (5-FU or Fluorouracil) is 100 per cent more effective at targeting tumours (rather than surrounding tissues) when administered using an optimised liposomal formulation.